Epidemic and Pandemic Preparedness and Prevention. Planning for national allocations of pandemic influenza medical countermeasures: considerations brief. WHO
This document presents comprehensive, ethics-based considerations to guide national decisions on allocating pandemic products such as vaccines, therapeutics, and diagnostics. Drawing on lessons from past pandemics, including COVID-19, it outlines how countries can design fair, transparent, and effective allocation systems that balance equity, efficiency, reciprocity, procedural fairness and other ethical principles. The document also considers key trade-offs, identifies unethical practices to avoid, and provides practical guidance on operationalizing allocation through data-driven criteria, governance mechanisms, monitoring and evaluation, and contingency planning. Overall, it offers a roadmap for building resilient, adaptable allocation approaches that promote health equity and maximize public health impact during pandemics.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 6 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 6 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 6 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 6 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 6 hours ago
[Go Top] [Close Window]


